By Viviane Trojan

Anvisa recently launched a public notice with the aim of selecting Startups involved in the research and development of medicines, in order … Anvisa opens its doors to Startups: Stepping towards Innovation in Medicines

Kasznar Leonardos is proud to be a contributor to the Legal 500’s “Brazil: Life Sciences” guide. Our partners Priscila Kashiwabara and Viviane … Kasznar Leonardos contributes to the “Brazil: Life Sciences” guide by The Legal 500

As announced by our firm in our Newsletter No. 67 of December 15, 2023, a position of the INPI’s Federal Attorney’s Office, … Brazilian Patent and Trademarks Office (INPI) allows amendments to patent applications during the appeal phase, subject to new criteria

We are pleased to announce that our partners Gabriel Leonardos, Claudio Barbosa and Viviane Trojan, alongside attorneys at law Jorge Tinoco and … Chambers and Partners’ Patent Litigation Guide 2024 is now available!

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. … 2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

As recently reported, the BRPTO announced a series of new guidelines regarding the processing of patent, trademark and industrial design applications. Check … Industrial Design Registration: new BRPTO opinion on the scope of appeal

On Tuesday, December 12, 2023, the BRPTO published new rules that limit applicants’ acts in the administrative process for granting patents. At the … The BRPTO ruled that it is not possible to amend a patent application during the appeal phase

Starting February 6, 2024, generic and branded-generic (“similar”) drugs will be allowed to have different labels than their respective standard labels with … Anvisa approves skinny labeling practice in Brazil

The Interministerial Group on Intellectual Property (“GIPI’, in the Portuguese acronym), has announced its 2023-2025 Action Plan for implementing the Brazilian Intellectual … 2023 – 2025 Action Plan for the Brazilian Intellectual Property National Strategy Announced by GIPI

The chapter “Designs,” authored by our partners Viviane Trojan, Tarso Mesquita Machado, Fábio Ferreira, and specialist Felipe Florentino Lisboa, has been published in Lexology’s special … Lexology GTDT – Designs 2024

The chapter “Pharma & Medical Device Regulation,” authored by our partners Claudio Barbosa, Viviane Trojan and attorney at law Giovanna Mezher, has … Lexology GTDT – Pharma & Medical Device Regulation 2024

The National Health Surveillance Agency (ANVISA) has approved the opening of a Public Consultation to amend the regulation of biosimilar medicines in Brazil … Green light from ANVISA regarding the registration of biosimilar medicines in Brazil

The World Intellectual Property Organization (WIPO) has just published this year’s edition of its Global Innovation Index (GII). Among the 132 economies included in … Brazil climbs five positions and reaches Top 50 in WIPO’S Global Innovation Index 2023 Ranking

Check out the article “On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brasil”,  published on IAM Media, authored by … On the cusp of change: patent landscape overhaul is good news for healthcare innovation in Brazil

The approval of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure moves … Approval of the Budapest Treaty moves forward in Brazil for International Recognition of the Deposit of Microorganism.